Nuvectis Pharma Vs. Calidi Biotherapeutics Industry Stock Comparison

Sell

11

NVCT
Nuvectis Pharma

Last Price:

4.68

Seasonality Move:

33.69%

Buy

52

CLDI
Calidi Biotherapeutics

Last Price:

1.87

Seasonality Move:

-23.01%

Sell

11

Nuvectis Pharma (NVCT) is a Sell

Is Nuvectis Pharma a Buy, Sell or Hold?

The current Nuvectis Pharma [NVCT] share price is $4.70. The Score for NVCT is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
NVCT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Buy

52

Calidi Biotherapeutics (CLDI) is a Buy

Is Calidi Biotherapeutics a Buy, Sell or Hold?

The current Calidi Biotherapeutics [CLDI] share price is $1.85. The Score for CLDI is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
CLDI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NVCT Stock Price Chart

What is Nuvectis Pharma's stock price today?

The Nuvectis Pharma share price today is $4.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVCT is experiencing slight buying pressure.

CLDI Stock Price Chart

What is Calidi Biotherapeutics's stock price today?

The Calidi Biotherapeutics share price today is $1.85
The current trend is moderately bearish and CLDI is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVCT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.6	Sell
Relative Strength Index (14 RSI):	37.53	Sell
Chaikin Money Flow:	3113	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(3.76 - 8.06)	Sell
Bollinger Bands (100):	(5.29 - 7.85)	Sell

CLDI Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.05	Buy
Relative Strength Index (14 RSI):	48.19	Sell
Chaikin Money Flow:	1172230	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.77 - 2.41)	Sell
Bollinger Bands (100):	(1.04 - 1.92)	Buy

NVCT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	4.78	Sell
20-day SMA:	4.94	Sell
50-day SMA:	6.55	Sell
200-day SMA:	6.95	Sell
8-day EMA:	4.81	Sell
20-day EMA:	5.33	Sell
50-day EMA:	6.09	Sell
200-day EMA:	7.12	Sell

CLDI Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.94	Sell
20-day SMA:	2.08	Sell
50-day SMA:	1.62	Buy
200-day SMA:	2.35	Sell
8-day EMA:	1.94	Sell
20-day EMA:	1.95	Sell
50-day EMA:	1.76	Buy
200-day EMA:	7.38	Sell

Nuvectis Pharma Earnings Growth & NVCT Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Calidi Biotherapeutics Earnings Growth & CLDI Earnings Dates

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.72 per share, and an increase next year of $0.29 per share.

Nuvectis Pharma Technical Analysis

	Dec 2	Dec 3	Dec 4	Dec 5	Dec 6	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13
	Dec
	02	03	04	05	06	09	10	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Calidi Biotherapeutics Technical Analysis

	Dec 2	Dec 3	Dec 4	Dec 5	Dec 6	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13
	Dec
	02	03	04	05	06	09	10	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):